Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015), is a controversial decision of the Federal Circuit in which the court applied...

the "540 patent" (US 6258540 ). The cases are Sequenom Inc. v. Natera Inc. 12-cv-0184, Sequenom v. Ariosa Diagnostics Inc., 12-cv-0189, U.S. District Court...

(Gottschalk v. Benson, Parker v. Flook), but their new and useful applications may be patentable (Diamond v. Diehr). The Mayo, Myriad and Ariosa v. Sequenom patents...

corresponding to the fetus's father in the blood of pregnant women in Ariosa v. Sequenom), a patent will be denied, as not meeting statutory subject matter...

Collaborative Services v. Prometheus Laboratories, Inc., or that pregnant woman's blood contains DNA of fetus' father as in Ariosa v. Sequenom) is not patent-ineligible...

Association for Molecular Pathology v. Myriad Genetics, Inc. DDR Holdings, LLC v. Hotels.com Ariosa v. Sequenom Genetic Technologies v. Merial patent-eligibility...

adopting Judge Newman's position. In 2015 Newman wrote a dissent in Ariosa v. Sequenom that criticized Federal Circuit's holding on patent-eligible subject...

controversy, as discussed in Mayo v. Prometheus and Ariosa v. Sequenom. The subsequent opinion of the Supreme Court in Alice Corp. v. CLS Bank International confirmed...